The sensitive detection and quantitation of antibody to HCV by using a microsphere-based immunoassay and flow cytometry

被引:0
作者
McHugh, TM
Viele, MK
Chase, ES
Recktenwald, DJ
机构
[1] CYTEK DEV,FREMONT,CA
[2] AMCELL CORP,SUNNYVALE,CA
来源
CYTOMETRY | 1997年 / 29卷 / 02期
关键词
hepatitis C viruses; hepatitis C antibodies; microspheres; flow cytometry; immunoassay; serodiagnosis; immunologic techniques;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Antibody to HCV core and NS3 was quantified by using a microsphere immunoassay and flow cytometry, Antibody to core and NS3 was elevated in the 85 seropositive blood donors tested. The amount of either antibody varied over two logs although greater variation was seen with the antibody to NS3 than was seen with antibody to core. In three documented acute HCV cases, the microsphere assay detected antibody prior to antibody detection using the reference methods, Twenty donor samples were indeterminate by the reference methods: 45% of these were Indeterminate with the microsphere assay while 25% mere negative and 30% were positive. As compared to enzyme immunoassay the microsphere assay showed a 5-fold increase in sensitivity. The microsphere assay demonstrated increased sensitivity for the quantification of specific antibody to HCV core and NS3 and was useful in resolving a significant proportion of indeterminate samples. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 20 条
[1]  
ALTER MJ, 1994, ARCH PATHOL LAB MED, V118, P342
[2]  
*AM ASS BLOOD BANK, 1995, ASS B AABB, V957
[3]   RECOMBINANT IMMUNOBLOT ASSAY REACTION PATTERNS AND HEPATITIS-C VIRUS-RNA IN BLOOD-DONORS AND NON-A, NON-B-HEPATITIS PATIENTS [J].
BRESTERS, D ;
ZAAIJER, HL ;
CUYPERS, HTM ;
REESINK, HW ;
WINKEL, IN ;
VANEXELOEHLERS, PJ ;
VANDRIMMELEN, AAJ ;
JANSEN, PLM ;
VANDERPOEL, CL ;
LELIE, PN .
TRANSFUSION, 1993, 33 (08) :634-638
[4]  
COUROUCE AM, 1994, LANCET, V343, P853
[5]   THE DECLINING RISK OF POSTTRANSFUSION HEPATITIS-C VIRUS-INFECTION [J].
DONAHUE, JG ;
MUNOZ, A ;
NESS, PM ;
BROWN, DE ;
YAWN, DH ;
MCALLISTER, HA ;
REITZ, BA ;
NELSON, KE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (06) :369-373
[6]   LACK OF PROTECTIVE IMMUNITY AGAINST REINFECTION WITH HEPATITIS-C VIRUS [J].
FARCI, P ;
ALTER, HJ ;
GOVINDARAJAN, S ;
WONG, DC ;
ENGLE, R ;
LESNIEWSKI, RR ;
MUSHAHWAR, IK ;
DESAI, SM ;
MILLER, RH ;
OGATA, N ;
PURCELL, RH .
SCIENCE, 1992, 258 (5079) :135-140
[7]   LATE SEROCONVERSION AND HIGH CHRONICITY RATE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH HEMATOLOGIC DISORDERS [J].
GRUBER, A ;
NORDER, H ;
MAGNIUS, L ;
ROTZEN, M ;
RUBIO, C ;
GRILLNER, L ;
BJORKHOLM, M .
ANNALS OF ONCOLOGY, 1993, 4 (03) :229-234
[8]   ANTIBODY TO HEPATITIS-C VIRUS 2ND ENVELOPE (HCV-E2) GLYCOPROTEIN - A NEW MARKER OF HCV INFECTION CLOSELY ASSOCIATED WITH VIREMIA [J].
LESNIEWSKI, R ;
OKASINSKI, G ;
CARRICK, R ;
VANSANT, C ;
DESAI, S ;
JOHNSON, R ;
SCHEFFEL, J ;
MOORE, B .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (04) :415-422
[9]   HEPATITIS-C VIRUS (HCV) VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-SERONEGATIVE AND VIRUS-SEROPOSITIVE PATIENTS WITH INDETERMINATE HCV RECOMBINANT IMMUNOBLOT ASSAY [J].
MARCELLIN, P ;
MARTINOTPEIGNOUX, M ;
ELIAS, A ;
BRANGER, M ;
COURTOIS, F ;
LEVEL, R ;
ERLINGER, S ;
BENHAMOU, JP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :433-435
[10]  
MCHUGH TM, 1994, METHOD CELL BIOL, V42, P575